Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Genetics and hyperphenylalaninemias in 1992].

R L Touraine1, P Guibaud

  • 1Service de pédiatrie-génétique, hôpital Debrousse, Lyon, France.

Pediatrie
|January 1, 1992
PubMed
Summary

Phenylalanine hydroxylase (PAH) deficiency causes hyperphenylalaninemias. Genotype-phenotype prediction may guide better therapies, including gene therapy for severe phenylketonuria (PKU) cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic neuromyotonia as a phenotypic variation associated with a new mutation in the KCNA1 gene.

Journal of neurology·2006
Same author

Is the CAG repeat of mitochondrial DNA polymerase gamma (POLG) associated with male infertility? A multi-centre French study.

Human reproduction (Oxford, England)·2005
Same author

Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources.

Bone marrow transplantation·2003
Same author

A simple, low cost and non-invasive method for screening Y-chromosome microdeletions in infertile men.

Human reproduction (Oxford, England)·2003
Same author

Impaired autonomic control of the heart by SOX10 mutation.

European journal of pediatrics·2001
Same author

[Persistent hyperplastic primary vitreous syndrome in a girl with Aicardi syndrome].

Journal francais d'ophtalmologie·2000

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Disorders

Background:

  • Hyperphenylalaninemias stem from enzymatic impairments, primarily phenylalanine hydroxylase (PAH) deficiency.
  • The PAH gene is a single copy, well-characterized through cloning, sequencing, and mapping.
  • Phenylketonuria (PKU) is a common genetic metabolic disorder affecting Caucasians.

Purpose of the Study:

  • To investigate the genetic basis of phenylalanine hydroxylase (PAH) deficiency.
  • To explore genotype-phenotype correlations for improved therapeutic strategies.
  • To understand the origin and high frequency of PKU in Caucasian populations.

Main Methods:

  • Characterization of PAH gene mutations.
  • Analysis of Restriction Fragment Length Polymorphism (RFLP) haplotypes in affected families.
  • Utilizing a murine model for PKU research.

Main Results:

  • Twenty-one PAH mutations identified, accounting for less than half of French patient genotypes.
  • RFLP haplotype analysis proved informative in 90% of families studied.
  • No linkage disequilibrium was found between PKU and specific haplotypes.

Conclusions:

  • Genotype-phenotype prediction in PAH deficiency shows promise for personalized therapeutic approaches.
  • Gene therapy may be a future option for severe PKU cases.
  • A selective advantage for heterozygous individuals carrying a PKU allele is hypothesized for the disease's high frequency in Caucasians.

Related Experiment Videos